W
WAVEMAN · COMPANY
MDWD · Mediwound Ltd.
> Ask across nine datasets ⌘K
LIVE
TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475TEAM-0.32% 13F +439META+3.01% 13F +2,694RCG-2.04% CLUSTERUTHR-4.03% 13F +425CRWV+4.49% 13F +693CRM+2.92% 13F +1,018CVNA-0.98% 13F +794TPL-0.71% 13F +444NET+4.32% 13F +710MSTR+17.56% 13F +526DELL+4.91% 13F +1,203CRWD+5.68% 13F +1,382ANET+1.22% 13F +1,323COIN+10.14% 13F +475
← ALL COMPANIES

MDWD

MediWound Ltd.
PHARMA & BIOTECH · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS · CIK 0001593984
CLUSTER · 3 INSIDERSFORM 144 · 1☆ WATCH
INSIDER NET · 180D
$136.0K
open-market buys minus sells, Form 4 codes P and S
INSIDER BUYERS · 180D
3
CONGRESS BUYERS · 1Y
0
FUNDS ADDED · QTR
45
13F, latest reported quarter
REVENUE GROWTH
-
XBRL, annual
NET MARGIN
-
SEVEN FACTS, RANKED AGAINST THE SECTOR · RANK IS NOT A FORECAST
INSIDERS
net +$136.0K over 180 days
-$52 over 90 days
more than 77% of Pharma & Biotech
CONGRESS
no member of Congress has reported trading it
FUNDS
45 funds added or opened last quarter
below 57% of Pharma & Biotech
REVENUE
no revenue reported in any filing
MARGIN
no margin: this company reports no revenue to divide by
BUYBACKS
no share repurchases reported
SHORT
12.6% of shares outstanding short · 24.2 days to cover · settled 2026-07-31
more than 86% of Pharma & Biotech
THE SITUATION · EVERY LINE IS ONE RULE OVER ONE DATASET
3 insiders bought a net $136.0K while the stock fell 26% over six months, but 1 Form 144 notice ($50.3K) are queued to sell.
45 funds added or opened positions in the latest 13F quarter, of 81 holders.
The year, with the filings on it
Total return indexed to 100 over the last 12 months · every marker is a federal filing, placed at its date — hover any marker for the detail
TOTAL 12M RETURN -20.4%
-20.4%12M
-24%-10%+4%+19%2025-092025-102025-122026-032026-052026-072026-09 2026-06-03 · SHAMIR NACHUM bought $81.5K2026-06-01 · Fox David Morton bought $25.2K2026-06-01 · Fox David Morton bought $24.6K2026-09-01 · Rubinstein Samuel sold $6.7K2026-09-01 · Rubinstein Samuel bought $6.6K2026-06-03 · SHAMIR NACHUM bought $2.4K2026-05-29 · Rubinstein Samuel bought $2.1K2026-06-01 · Fox David Morton bought $1422026-08-28 · Shmulik Hess filed to sell $50.3K
INSIDER BUYINSIDER SELLFORM 144
INDEXED RETURN, DIVIDEND-ADJUSTED — NOT A PRICE CHART · LARGE TRADES DRAWN FIRST WHEN A NAME FILES HEAVILY
Live price
Daily candles from TradingView, on their licence — no filings are marked on this one
WHY THIS NAME IS ON THE DESK
3 insiders reported buying shares.
The record shows a net $136.0K bought by insiders over 180 days, 45 funds added last quarter, $50.3K in planned Form 144 sales. Every figure is a federal filing, dated the day it became public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector from the SEC's own SIC classification
UTHRCPIXMRNAREGNLLYALNYELFCITRMDGLDNAVRTXNUVL
Insider transactions
Form 4 purchases and sales (codes P and S) — grants, option exercises and preferred conversions excluded

Over the last 180 days, MediWound Ltd. insiders bought a net $136.0K of stock across 8 Form 4 purchases and sales, with 3 insider(s) buying. Source: SEC Form 4 filings, as of 2026-09-05.

INSIDER
FILED
SHARES
VALUE
Rubinstein Samuel
Director
SELL
2026-09-01
525.0
$6.7K
Rubinstein Samuel
Director
BUY
2026-09-01
525.0
$6.6K
SHAMIR NACHUM
Director
BUY
2026-06-03
175.0
$2.4K
SHAMIR NACHUM
Director
BUY
2026-06-03
5,825.0
$81.5K
Fox David Morton
Director
BUY
2026-06-01
1,730.0
$24.6K
8 TRANSACTIONS ON RECORD

Showing the most recent few. Create a free account to see 3 more transactions on record, the cross-source screener and CSV export. We store only your email address, and there is no password to create.

Institutional holders
13F · holdings as of the latest quarter funds have reported
INVESTOR AB
872,093.0 sh
$12.8M
Yelin Lapidot Holdings Management Ltd.
758,169.0 sh
$11.1M
Rosalind Advisors, Inc.
749,054.0 sh
$11.0M
BlackRock, Inc.
525,929.0 sh
$7.7M
SPHERA FUNDS MANAGEMENT LTD.
273,192.0 sh
$4.0M
SCHEDULE 13D/G
No 5%+ ownership filings
Nobody has crossed 5% with a filing obligation. Absence is a fact here, not missing data.
Planned sales · Form 144
Filed before the sale — intent, not a trade
Shmulik Hess
FILED 2026-08-28
$50.3K
Fund concentration
N-PORT · funds ranked by how much of THEMSELVES they put in this stock — the conviction number 13F cannot show
Invesco NASDAQ Future Gen 200 ETF
$63.9K POSITION · AS OF 2026-02-28
0.5%
Small Cap Core Fund
$82.5K POSITION · AS OF 2026-03-31
0.0%
Health Sciences Trust
$36.8K POSITION · AS OF 2026-03-31
0.0%
VANGUARD RUSSELL 2000 GROWTH INDEX FUND
$142.0K POSITION · AS OF 2026-02-28
0.0%
Small Cap Index Fund
$84.3K POSITION · AS OF 2026-03-31
0.0%
Small Cap Index Trust
$31.2K POSITION · AS OF 2026-03-31
0.0%
SEC N-PORT, MONTHLY WITH A ~60-DAY PUBLIC LAG · FUNDS ≥ $10M · % = SHARE OF THE FUND'S OWN BOOK
Clinical pipeline
ClinicalTrials.gov · 6 registered trials, 3 still enrolling or running — a status change here is dated weeks before the press release
2
Phase 2
2 ACTIVE
3
Phase 3
1 ACTIVE
1
Not applicable
0 ACTIVE
TRIALS MATCHED TO THIS TICKER BY SPONSOR NAME · STUDIES RUN UNDER A SUBSIDIARY'S OWN NAME ARE NOT INCLUDED
Fundamentals
Annual figures from XBRL filings · pick a past date to see them exactly as the market knew them then — restatements and all
2025-122024-122023-122022-12
GROSS PROFIT$3.3M$2.6M$3.6M$13.2M
NET INCOME$-23.9M$-30.2M$-6.7M$-19.6M
SEC XBRL · FISCAL-YEAR PERIODS · AS KNOWN ON 2026-09-05 · NOBODY ELSE SHOWS FUNDAMENTALS AS OF A PAST DATE
W WAVEMAN

Public filings, honestly analyzed. Official US government sources in one desk — every figure carries the date it was filed, and the methodology is published, backtest included.

SEC FORM 4FORM 13F 13D/GFORM 144XBRL STOCK ACTCONTRACTSFEC CFPBNRC
PRODUCT
DeskBacktester CompaniesAccount
SUPPORT
FAQMethodology Contact
LEGAL
TermsPrivacy Accessibility
© 2026 WAVEMAN · SOURCE: SEC EDGAR & OFFICIAL GOVERNMENT DATA · NOT INVESTMENT ADVICE · CHART BY TRADINGVIEW · UPDATED 2026-09-05 ALL SYSTEMS LIVE FOR MACHINES →